Abstract
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Elasticity Imaging Techniques*
-
Fibrosis
-
Humans
-
Liver / pathology
-
Liver Cirrhosis / diagnostic imaging
-
Liver Cirrhosis / pathology
-
Non-alcoholic Fatty Liver Disease* / complications
-
Non-alcoholic Fatty Liver Disease* / diagnostic imaging
-
Non-alcoholic Fatty Liver Disease* / pathology